Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unilateral Transcranial Photobiomodulation for the Treatment of Opioid Cravings: A Blinded Placebo-Controlled Evaluation of Efficacy and Safety

NCT04417738 is registered in ClinicalTrials.gov with MindLight, LLC as lead sponsor.

NCT NCT04417738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04417738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unilateral Transcranial Photobiomodulation for the Treatment of Opioid Cravings: A Blinded Placebo-Controlled Evaluation of Efficacy and Safety
Lead sponsor
MindLight, LLC
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2019
Completion date
November 15, 2019
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

craving, depression, anxiety, opioid-use disorder